Evidence-based clinical practice Guidelines for Prostate Cancer (Summary - JUA 2006 Edition).
Kamidono
Sadao
S
Ohshima
Shinichi
S
Hirao
Yoshihiko
Y
Suzuki
Kazuhiro
K
Arai
Yoichi
Y
Fujimoto
Hiroyuki
H
Egawa
Shin
S
Akaza
Hideyuki
H
Hara
Isao
I
Hinotsu
Shiro
S
Kakehi
Yoshiyuki
Y
Hasegawa
Tomonori
T
D000368:Aged; D000369:Aged, 80 and over; D000726:Androgen Antagonists / Q000627:therapeutic use; D051517:Digital Rectal Examination; D019317:Evidence-Based Medicine / Q000379:methods; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors; D006801:Humans; D007564:Japan / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D020360:Neoadjuvant Therapy / Q000379:methods; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D009367:Neoplasm Staging / Q000379:methods; D010166:Palliative Care / Q000379:methods; D018579:Patient Selection; D011467:Prostate / Q000000981:diagnostic imaging / Q000473:pathology; D017430:Prostate-Specific Antigen / Q000378:metabolism; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000378:metabolism / Q000628:therapy*; D011878:Radiotherapy / Q000379:methods; D012307:Risk Factors; D014463:Ultrasonography; D014572:Urology / Q000379:methods* / Q000592:standards*
D000726:Androgen Antagonists; D007987:Gonadotropin-Releasing Hormone; D017430:Prostate-Specific Antigen